Price Estimate On Open, page-65

First of all whilst I think CGL’s start up price may well will be conservative, and if there is a P & D these factors do not concern me in the slightest.
What I am focusing on and impressed with specifically from an MM point of view, and I’ve backed it up by topping up via the share issue is to combat the possibility that the conservative approach of both the Australian Government particularly with a Federal Election in the wings and the medical profession in unison may throw up numerous road blocks restricting companies like ours getting on board the MM distribution train within our own borders, and if that occurs, the soon to be listed CGL has already spread its tentacles into various international MM trading arenas predominantly, though not exclusively through its link with the Canadians and in particular Canntab, along with the well documented Israeli MM research trendsetters.
Without factoring in Hemp which alone could deliver healthy returns to SHders and the possibility that the ugly duckling, that being Bauxite at some stage also delivers a ROI, the Canntab Asia distribution rights alone where supply restrictions I assume will be nowhere severe as here in good old Aus., IMHO a game plan has been set in place with a very positive tone for some bullish returns to all not overnight, next week or even in 6 months but definitely into the future.
Time will tell.